Sinopharm
1099.HK
#2517
Rank
โ‚ฌ6.09 B
Marketcap
1,95ย โ‚ฌ
Share price
-1.00%
Change (1 day)
-13.97%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚ฌ74.91 Billion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚ฌ74.91 Billion. In 2025 the company made a revenue of โ‚ฌ74.91 Billion an increase over the revenue in the year 2024 that were of โ‚ฌ72.97 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚ฌ74.91 B2.65%
2024โ‚ฌ72.97 B-5.1%
2023โ‚ฌ76.90 B5.42%
2022โ‚ฌ72.94 B-2.1%
2021โ‚ฌ74.50 B16.85%
2020โ‚ฌ63.76 B14.95%
2019โ‚ฌ55.47 B21.52%
2018โ‚ฌ45.64 B5.93%
2017โ‚ฌ43.09 B27.22%
2016โ‚ฌ33.87 B5.37%
2015โ‚ฌ32.14 B9.14%
2014โ‚ฌ29.45 B17.22%
2013โ‚ฌ25.12 B25.94%
2012โ‚ฌ19.94 B34.61%
2011โ‚ฌ14.82 B55.34%
2010โ‚ฌ9.54 B35.79%
2009โ‚ฌ7.02 B37.56%
2008โ‚ฌ5.10 B31.43%
2007โ‚ฌ3.88 B40.26%
2006โ‚ฌ2.77 B